HMPV Genotype | HMPV Sub-lineage | |||||||
---|---|---|---|---|---|---|---|---|
Characteristics | A, n = 40 | B, n = 41 | p | A2b, n = 25 | Unique A2 sub-lineage, n = 15 | B1, n = 25 | B2, n = 16 | p |
Sex | ||||||||
Male, n = 29 | 13 | 16 | 0.540b | 8 | 5 | 11 | 5 | 0.784b |
Female, n = 52 | 27 | 25 | 17 | 10 | 14 | 11 | ||
Age | ||||||||
< 65 years old, n = 65 | 32 | 33 | 0.956b | 20 | 12 | 22 | 11 | 0.516b |
≥ 65 years old, n = 16 | 8 | 8 | 5 | 3 | 3 | 5 | ||
mean (±SD) | 45.28 ± 18.26 | 46.15 ± 20.12 | 0.839a | 44.36 ± 18.68 | 46.80 ± 18.07 | 44.56 ± 17.63 | 48.63 ± 23.91 | 0.892c |
Ethnicity | ||||||||
Chinese, n = 19 | 12 | 7 | 0.402b | 6 | 6 | 2 | 5 | 0.144b |
Malay, n = 38 | 18 | 20 | 15 | 3 | 14 | 6 | ||
Indian, n = 21 | 8 | 13 | 3 | 5 | 9 | 4 | ||
Others, n = 3 | 2 | 1 | 1 | 1 | 0 | 1 | ||
Presence of Symptoms | ||||||||
Sneezing, n = 56 | 29 | 27 | 0.517b | 20 | 9 | 18 | 9 | 0.346b |
Nasal congestion, n = 54 | 23 | 31 | 0.084b | 14 | 9 | 21 | 10 | 0.166b |
Nasal discharge, n = 58 | 31 | 27 | 0.245b | 20 | 11 | 16 | 11 | 0.645b |
Cough, n = 80 | 40 | 40 | 0.320b | 25 | 15 | 24 | 16 | 0.519b |
Sore throat, n = 59 | 28 | 31 | 0.570b | 19 | 9 | 21 | 10 | 0.282b |
Hoarseness of voice, n = 72 | 36 | 36 | 0.753b | 23 | 13 | 23 | 13 | 0.680b |
Muscle ache, n = 56 | 26 | 30 | 0.426b | 17 | 9 | 18 | 12 | 0.812b |
Headache, n = 57 | 27 | 30 | 0.576b | 15 | 12 | 18 | 12 | 0.541b |
Estimated no. of days elapsed between symptom onset and enrollment date | ||||||||
≤ 1–2 days, n = 20 | 9 | 11 | 0.207b | 5 | 4 | 7 | 4 | 0.600b |
3–5 days, n = 36 | 15 | 21 | 11 | 4 | 12 | 9 | ||
≥ 6 days, n = 25 | 16 | 9 | 9 | 7 | 6 | 3 | ||
mean (±SD) | 5.15 ± 3.63 | 4.12 ± 2.55 | 0.143a | 4.56 ± 2.04 | 6.13 ± 5.28 | 4.20 ± 2.93 | 4.00 ± 1.80 | 0.211c |